
Publication|Articles|May 1, 2003
The American Journal of Managed Care
- May 2003
- Volume 9
- Issue 5
Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience
Author(s)Darren Kocs, MD, MHSA, A. Mark Fendrick, MD
Advertisement
Articles in this issue
over 22 years ago
Lansoprazole Overutilization: Methods for Step-Down TherapyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement















































